ELF4 bridges transcriptional and translational outputs to regulate inflammatory T Cells 3617
Abstract Description The transcription factor ELF4 generally acts as a brake on the immune system, as patients with Deficiency in ELF4 X-linked (DEX) exhibit symptoms of hyperinflammation. While it has been demonstrated by our lab that global loss of ELF4 results in hyper-cytokine release in macrophages and restrains Th17 differentiation in mice, the breadth and mechanisms of CD4+ T cell regulation by ELF4 remain enigmatic. Here, we show that loss of T cell-intrinsic ELF4 leads to enhanced interferon gamma (IFNγ) production at the protein, but not transcript, level. In line with this, absence of T cell-intrinsic ELF4 leads to decreased expression of several targets of the integrated stress response, demonstrated to be crucial in restraining cytokine production via inhibition of cap-dependent translation during initial activation of naïve T cells. Using stable isotope labeling with amino acids in cell culture (SILAC), we demonstrate ELF4 specifically limits the translation of IFNγ, while upregulating the production of factors known to inhibit cap-dependent translation, Eif4ebp1 and Eif4ebp2. T cell-intrinsic ELF4 deficiency in the context of infection with Lymphocytic Choriomeningitis virus resulted in enhanced IFNγ production by CD4+ T cells during initial infection as well as enhanced multi-cytokine production of memory CD4+ T cells. Thus, we elucidate an essential mechanism for restraining CD4+ T cell inflammatory potential dependent on regulation of the integrated stress response by ELF4. Funding Sources Mathers Foundation, Rainin Foundation, NIAID/NIH Topic Categories Immune Response Regulation: Molecular Mechanisms (IRM)
Authors
- Sam J. Olyha (ORCID: https://orcid.org/0000-0002-6915-3721)
- Mackenzie Bender (ORCID: https://orcid.org/0000-0002-0241-2426)
- Ujendra Kumar (ORCID: https://orcid.org/0000-0003-3619-1198)
- Dinesh Babu (ORCID: https://orcid.org/0000-0002-5922-1081)
- John Attanasio
- Víctor Miranda (ORCID: https://orcid.org/0000-0002-0371-9833)
- Molly L. Bucklin (ORCID: https://orcid.org/0000-0003-1388-686X)
- Jaspreet S Kohli (ORCID: https://orcid.org/0000-0002-4938-600X)
- Samuel A. Myers (ORCID: https://orcid.org/0000-0001-7636-0887)
- Toby M. Maher (ORCID: https://orcid.org/0000-0001-7192-9149)
- Jie Pan (ORCID: https://orcid.org/0000-0002-4993-298X)
- C. Lucas (ORCID: https://orcid.org/0000-0002-5754-0820)
- Peiying Shan (ORCID: https://orcid.org/0000-0003-2251-8428)
- A Muise
- Sindhura Siddapureddy
- A. Johnston (ORCID: https://orcid.org/0000-0002-9683-4952)
Institutions
- La Jolla Institute for Immunology (US)
- University of Toronto (CA)
- Yale University (US)
Publication Details
- Journal
- The Journal of Immunology
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1093/jimmun/vkaf283.1396
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ohio State University
- Pelotonia
- National Institutes of Health